ID: ALA5201277

Max Phase: Preclinical

Molecular Formula: C40H54N10O12S

Molecular Weight: 899.00

Associated Items:

Representations

Canonical SMILES:  C[C@H]([C@@H]1NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSc3[nH]c4ccccc4c3C[C@H](NC1=O)C(=O)NCC(=O)N[C@H](C1CCCC1)C(=O)NCC(=O)N2)[C@@H](O)CO

Standard InChI:  InChI=1S/C40H54N10O12S/c1-18(28(53)16-51)32-38(61)45-24-11-22-21-8-4-5-9-23(21)47-39(22)63-17-26(35(58)46-25(12-29(41)54)40(62)50-15-20(52)10-27(50)36(59)49-32)44-30(55)13-43-37(60)33(19-6-2-3-7-19)48-31(56)14-42-34(24)57/h4-5,8-9,18-20,24-28,32-33,47,51-53H,2-3,6-7,10-17H2,1H3,(H2,41,54)(H,42,57)(H,43,60)(H,44,55)(H,45,61)(H,46,58)(H,48,56)(H,49,59)/t18-,20+,24-,25-,26-,27-,28-,32-,33+/m0/s1

Standard InChI Key:  ISFOBMMQRJURCT-BBNTXBMPSA-N

Associated Targets(non-human)

CHO 4503 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 899.00Molecular Weight (Monoisotopic): 898.3643AlogP: -4.50#Rotatable Bonds: 6
Polar Surface Area: 343.58Molecular Species: NEUTRALHBA: 13HBD: 12
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.11CX Basic pKa: CX LogP: -5.89CX LogD: -5.89
Aromatic Rings: 2Heavy Atoms: 63QED Weighted: 0.13Np Likeness Score: 0.89

References

1. Todorovic M, Rivollier P, Wong AAWL, Wang Z, Pryyma A, Nguyen TT, Newell KC, Froelich J, Perrin DM..  (2022)  Rationally Designed Amanitins Achieve Enhanced Cytotoxicity.,  65  (15.0): [PMID:35696491] [10.1021/acs.jmedchem.1c02226]

Source